Global E Coli Testing
Global E Coli Testing

E Coli Testing Comprehensive Study by Type (Enzyme Immunoassays (EIA), Polymerase Chain Reaction (PCR) Tests, Others), Environmental Testing (Enzyme Substrate Methods, Membrane Filtration (MF), Multiple Tube Fermentation (MTF)), End User (Clinical Testing Methods, Diagnostic Laboratories, Hospital, Physician Offices, Environmental Testing, Bottled Water Suppliers, Home and Drinking Water Suppliers, Others (Government Agencies, etc.), Waste Water Treatment Organizations) Players and Region - Global Market Outlook to 2026

E Coli Testing Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Jun 2021 Edition 208 Pages 189 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global E Coli Testing Market Overview:
Escherichia coli is a type of bacteria or germ that can be found in the environment, foods, and the guts of people and other warm-blooded animals.The global Escherichia coli testing market is being driven by rising government funding and the emergence of drug-resistant forms of Escherichia coli (E. coli).One of the primary factors driving a favourable outlook for the market is the rising prevalence of water-borne disorders such as diarrhoea and hemolytic uremic syndrome (HUS), as well as the growing need for clean drinking water around the world.

Growth Drivers
  • Rise in Prevalence of Diarrhea and Hemolytic Uremic Syndrome (HUS)
  • Increase in Number of Water-borne Disease

Roadblocks
  • High Cost of E. coli Treatment

Opportunities
  • Increasing Government Support and Development of Drug-resistant Species of Escherichia coli (E. coli)
  • Extensive Research and Development (R&D) Activities in the Field of Microbiology

Challenges
  • Reliability of the Testing Kits


Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Alere (United States), Becton, Dickinson and Company (United States), BioMerieux (France), Meridian Bioscience (United States), Accugen Laboratories (United States), Bio-Rad Laboratories (United States), Diasorin (Italy), EIKEN CHEMICAL (Japan), Enzo Life Sciences (United States) and InstantLabs (United States). Analyst at AMA Research see United States Players to retain maximum share of Global E Coli Testing market by 2026. Considering Market by Environmental Testing, the sub-segment i.e. Enzyme Substrate Methods will boost the E Coli Testing market. Considering Market by End User, the sub-segment i.e. Clinical Testing Methods will boost the E Coli Testing market.

In July 2019, Bio-Rad will be introducing a test kit that can precisely detect Shiga toxin-producing E. coli pathogens in the food products, including meat and poultry.

What Can be Explored with the E Coli Testing Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global E Coli Testing Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in E Coli Testing
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global E Coli Testing market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in E Coli Testing market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, E Coli Testing Provider, Venture Capitalists and Private Equity Firms and End-Use Industry.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Frequently Asked Questions (FAQ):

1. What is the growth rate predicted for the Global E Coli Testing Market?
The E Coli Testing market is expected to see a CAGR of % during projected year 2020 to 2026.

2. Who are the top performing companies in E Coli Testing Market?
Top performing companies in the Global E Coli Testing market are Alere (United States), Becton, Dickinson and Company (United States), BioMerieux (France), Meridian Bioscience (United States), Accugen Laboratories (United States), Bio-Rad Laboratories (United States), Diasorin (Italy), EIKEN CHEMICAL (Japan), Enzo Life Sciences (United States) and InstantLabs (United States), to name a few.

3. What trending factors would impact E Coli Testing Market growth most?
"High Demand for Enzyme Substrate Segment" is seen as one of major influencing trends for E Coli Testing Market during projected period 2020-2026.

Report Objectives / Segmentation Covered
By Type
  • Enzyme Immunoassays (EIA)
  • Polymerase Chain Reaction (PCR) Tests
  • Others
By Environmental Testing
  • Enzyme Substrate Methods
  • Membrane Filtration (MF)
  • Multiple Tube Fermentation (MTF)

By End User
  • Clinical Testing Methods
  • Diagnostic Laboratories
  • Hospital
  • Physician Offices
  • Environmental Testing
  • Bottled Water Suppliers
  • Home and Drinking Water Suppliers
  • Others (Government Agencies, etc.)
  • Waste Water Treatment Organizations

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rise in Prevalence of Diarrhea and Hemolytic Uremic Syndrome (HUS)
      • 3.2.2. Increase in Number of Water-borne Disease
    • 3.3. Market Challenges
      • 3.3.1. Reliability of the Testing Kits
    • 3.4. Market Trends
      • 3.4.1. High Demand for Enzyme Substrate Segment
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global E Coli Testing, by Type, Environmental Testing, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global E Coli Testing (Value)
      • 5.2.1. Global E Coli Testing by: Type (Value)
        • 5.2.1.1. Enzyme Immunoassays (EIA)
        • 5.2.1.2. Polymerase Chain Reaction (PCR) Tests
        • 5.2.1.3. Others
      • 5.2.2. Global E Coli Testing by: Environmental Testing (Value)
        • 5.2.2.1. Enzyme Substrate Methods
        • 5.2.2.2. Membrane Filtration (MF)
        • 5.2.2.3. Multiple Tube Fermentation (MTF)
      • 5.2.3. Global E Coli Testing by: End User (Value)
        • 5.2.3.1. Clinical Testing Methods
        • 5.2.3.2. Diagnostic Laboratories
        • 5.2.3.3. Hospital
        • 5.2.3.4. Physician Offices
        • 5.2.3.5. Environmental Testing
        • 5.2.3.6. Bottled Water Suppliers
        • 5.2.3.7. Home and Drinking Water Suppliers
        • 5.2.3.8. Others (Government Agencies, etc.)
        • 5.2.3.9. Waste Water Treatment Organizations
      • 5.2.4. Global E Coli Testing Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. E Coli Testing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Alere (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Becton, Dickinson and Company (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. BioMerieux (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Meridian Bioscience (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Accugen Laboratories (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Bio-Rad Laboratories (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Diasorin (Italy)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. EIKEN CHEMICAL (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Enzo Life Sciences (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. InstantLabs (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global E Coli Testing Sale, by Type, Environmental Testing, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global E Coli Testing (Value)
      • 7.2.1. Global E Coli Testing by: Type (Value)
        • 7.2.1.1. Enzyme Immunoassays (EIA)
        • 7.2.1.2. Polymerase Chain Reaction (PCR) Tests
        • 7.2.1.3. Others
      • 7.2.2. Global E Coli Testing by: Environmental Testing (Value)
        • 7.2.2.1. Enzyme Substrate Methods
        • 7.2.2.2. Membrane Filtration (MF)
        • 7.2.2.3. Multiple Tube Fermentation (MTF)
      • 7.2.3. Global E Coli Testing by: End User (Value)
        • 7.2.3.1. Clinical Testing Methods
        • 7.2.3.2. Diagnostic Laboratories
        • 7.2.3.3. Hospital
        • 7.2.3.4. Physician Offices
        • 7.2.3.5. Environmental Testing
        • 7.2.3.6. Bottled Water Suppliers
        • 7.2.3.7. Home and Drinking Water Suppliers
        • 7.2.3.8. Others (Government Agencies, etc.)
        • 7.2.3.9. Waste Water Treatment Organizations
      • 7.2.4. Global E Coli Testing Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. E Coli Testing: by Type(USD Million)
  • Table 2. E Coli Testing Enzyme Immunoassays (EIA) , by Region USD Million (2015-2020)
  • Table 3. E Coli Testing Polymerase Chain Reaction (PCR) Tests , by Region USD Million (2015-2020)
  • Table 4. E Coli Testing Others , by Region USD Million (2015-2020)
  • Table 5. E Coli Testing: by Environmental Testing(USD Million)
  • Table 6. E Coli Testing Enzyme Substrate Methods , by Region USD Million (2015-2020)
  • Table 7. E Coli Testing Membrane Filtration (MF) , by Region USD Million (2015-2020)
  • Table 8. E Coli Testing Multiple Tube Fermentation (MTF) , by Region USD Million (2015-2020)
  • Table 9. E Coli Testing: by End User(USD Million)
  • Table 10. E Coli Testing Clinical Testing Methods , by Region USD Million (2015-2020)
  • Table 11. E Coli Testing Diagnostic Laboratories , by Region USD Million (2015-2020)
  • Table 12. E Coli Testing Hospital , by Region USD Million (2015-2020)
  • Table 13. E Coli Testing Physician Offices , by Region USD Million (2015-2020)
  • Table 14. E Coli Testing Environmental Testing , by Region USD Million (2015-2020)
  • Table 15. E Coli Testing Bottled Water Suppliers , by Region USD Million (2015-2020)
  • Table 16. E Coli Testing Home and Drinking Water Suppliers , by Region USD Million (2015-2020)
  • Table 17. E Coli Testing Others (Government Agencies, etc.) , by Region USD Million (2015-2020)
  • Table 18. E Coli Testing Waste Water Treatment Organizations , by Region USD Million (2015-2020)
  • Table 19. South America E Coli Testing, by Country USD Million (2015-2020)
  • Table 20. South America E Coli Testing, by Type USD Million (2015-2020)
  • Table 21. South America E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 22. South America E Coli Testing, by End User USD Million (2015-2020)
  • Table 23. Brazil E Coli Testing, by Type USD Million (2015-2020)
  • Table 24. Brazil E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 25. Brazil E Coli Testing, by End User USD Million (2015-2020)
  • Table 26. Argentina E Coli Testing, by Type USD Million (2015-2020)
  • Table 27. Argentina E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 28. Argentina E Coli Testing, by End User USD Million (2015-2020)
  • Table 29. Rest of South America E Coli Testing, by Type USD Million (2015-2020)
  • Table 30. Rest of South America E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 31. Rest of South America E Coli Testing, by End User USD Million (2015-2020)
  • Table 32. Asia Pacific E Coli Testing, by Country USD Million (2015-2020)
  • Table 33. Asia Pacific E Coli Testing, by Type USD Million (2015-2020)
  • Table 34. Asia Pacific E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 35. Asia Pacific E Coli Testing, by End User USD Million (2015-2020)
  • Table 36. China E Coli Testing, by Type USD Million (2015-2020)
  • Table 37. China E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 38. China E Coli Testing, by End User USD Million (2015-2020)
  • Table 39. Japan E Coli Testing, by Type USD Million (2015-2020)
  • Table 40. Japan E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 41. Japan E Coli Testing, by End User USD Million (2015-2020)
  • Table 42. India E Coli Testing, by Type USD Million (2015-2020)
  • Table 43. India E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 44. India E Coli Testing, by End User USD Million (2015-2020)
  • Table 45. South Korea E Coli Testing, by Type USD Million (2015-2020)
  • Table 46. South Korea E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 47. South Korea E Coli Testing, by End User USD Million (2015-2020)
  • Table 48. Taiwan E Coli Testing, by Type USD Million (2015-2020)
  • Table 49. Taiwan E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 50. Taiwan E Coli Testing, by End User USD Million (2015-2020)
  • Table 51. Australia E Coli Testing, by Type USD Million (2015-2020)
  • Table 52. Australia E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 53. Australia E Coli Testing, by End User USD Million (2015-2020)
  • Table 54. Rest of Asia-Pacific E Coli Testing, by Type USD Million (2015-2020)
  • Table 55. Rest of Asia-Pacific E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 56. Rest of Asia-Pacific E Coli Testing, by End User USD Million (2015-2020)
  • Table 57. Europe E Coli Testing, by Country USD Million (2015-2020)
  • Table 58. Europe E Coli Testing, by Type USD Million (2015-2020)
  • Table 59. Europe E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 60. Europe E Coli Testing, by End User USD Million (2015-2020)
  • Table 61. Germany E Coli Testing, by Type USD Million (2015-2020)
  • Table 62. Germany E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 63. Germany E Coli Testing, by End User USD Million (2015-2020)
  • Table 64. France E Coli Testing, by Type USD Million (2015-2020)
  • Table 65. France E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 66. France E Coli Testing, by End User USD Million (2015-2020)
  • Table 67. Italy E Coli Testing, by Type USD Million (2015-2020)
  • Table 68. Italy E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 69. Italy E Coli Testing, by End User USD Million (2015-2020)
  • Table 70. United Kingdom E Coli Testing, by Type USD Million (2015-2020)
  • Table 71. United Kingdom E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 72. United Kingdom E Coli Testing, by End User USD Million (2015-2020)
  • Table 73. Netherlands E Coli Testing, by Type USD Million (2015-2020)
  • Table 74. Netherlands E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 75. Netherlands E Coli Testing, by End User USD Million (2015-2020)
  • Table 76. Rest of Europe E Coli Testing, by Type USD Million (2015-2020)
  • Table 77. Rest of Europe E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 78. Rest of Europe E Coli Testing, by End User USD Million (2015-2020)
  • Table 79. MEA E Coli Testing, by Country USD Million (2015-2020)
  • Table 80. MEA E Coli Testing, by Type USD Million (2015-2020)
  • Table 81. MEA E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 82. MEA E Coli Testing, by End User USD Million (2015-2020)
  • Table 83. Middle East E Coli Testing, by Type USD Million (2015-2020)
  • Table 84. Middle East E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 85. Middle East E Coli Testing, by End User USD Million (2015-2020)
  • Table 86. Africa E Coli Testing, by Type USD Million (2015-2020)
  • Table 87. Africa E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 88. Africa E Coli Testing, by End User USD Million (2015-2020)
  • Table 89. North America E Coli Testing, by Country USD Million (2015-2020)
  • Table 90. North America E Coli Testing, by Type USD Million (2015-2020)
  • Table 91. North America E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 92. North America E Coli Testing, by End User USD Million (2015-2020)
  • Table 93. United States E Coli Testing, by Type USD Million (2015-2020)
  • Table 94. United States E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 95. United States E Coli Testing, by End User USD Million (2015-2020)
  • Table 96. Canada E Coli Testing, by Type USD Million (2015-2020)
  • Table 97. Canada E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 98. Canada E Coli Testing, by End User USD Million (2015-2020)
  • Table 99. Mexico E Coli Testing, by Type USD Million (2015-2020)
  • Table 100. Mexico E Coli Testing, by Environmental Testing USD Million (2015-2020)
  • Table 101. Mexico E Coli Testing, by End User USD Million (2015-2020)
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. E Coli Testing: by Type(USD Million)
  • Table 113. E Coli Testing Enzyme Immunoassays (EIA) , by Region USD Million (2021-2026)
  • Table 114. E Coli Testing Polymerase Chain Reaction (PCR) Tests , by Region USD Million (2021-2026)
  • Table 115. E Coli Testing Others , by Region USD Million (2021-2026)
  • Table 116. E Coli Testing: by Environmental Testing(USD Million)
  • Table 117. E Coli Testing Enzyme Substrate Methods , by Region USD Million (2021-2026)
  • Table 118. E Coli Testing Membrane Filtration (MF) , by Region USD Million (2021-2026)
  • Table 119. E Coli Testing Multiple Tube Fermentation (MTF) , by Region USD Million (2021-2026)
  • Table 120. E Coli Testing: by End User(USD Million)
  • Table 121. E Coli Testing Clinical Testing Methods , by Region USD Million (2021-2026)
  • Table 122. E Coli Testing Diagnostic Laboratories , by Region USD Million (2021-2026)
  • Table 123. E Coli Testing Hospital , by Region USD Million (2021-2026)
  • Table 124. E Coli Testing Physician Offices , by Region USD Million (2021-2026)
  • Table 125. E Coli Testing Environmental Testing , by Region USD Million (2021-2026)
  • Table 126. E Coli Testing Bottled Water Suppliers , by Region USD Million (2021-2026)
  • Table 127. E Coli Testing Home and Drinking Water Suppliers , by Region USD Million (2021-2026)
  • Table 128. E Coli Testing Others (Government Agencies, etc.) , by Region USD Million (2021-2026)
  • Table 129. E Coli Testing Waste Water Treatment Organizations , by Region USD Million (2021-2026)
  • Table 130. South America E Coli Testing, by Country USD Million (2021-2026)
  • Table 131. South America E Coli Testing, by Type USD Million (2021-2026)
  • Table 132. South America E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 133. South America E Coli Testing, by End User USD Million (2021-2026)
  • Table 134. Brazil E Coli Testing, by Type USD Million (2021-2026)
  • Table 135. Brazil E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 136. Brazil E Coli Testing, by End User USD Million (2021-2026)
  • Table 137. Argentina E Coli Testing, by Type USD Million (2021-2026)
  • Table 138. Argentina E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 139. Argentina E Coli Testing, by End User USD Million (2021-2026)
  • Table 140. Rest of South America E Coli Testing, by Type USD Million (2021-2026)
  • Table 141. Rest of South America E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 142. Rest of South America E Coli Testing, by End User USD Million (2021-2026)
  • Table 143. Asia Pacific E Coli Testing, by Country USD Million (2021-2026)
  • Table 144. Asia Pacific E Coli Testing, by Type USD Million (2021-2026)
  • Table 145. Asia Pacific E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 146. Asia Pacific E Coli Testing, by End User USD Million (2021-2026)
  • Table 147. China E Coli Testing, by Type USD Million (2021-2026)
  • Table 148. China E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 149. China E Coli Testing, by End User USD Million (2021-2026)
  • Table 150. Japan E Coli Testing, by Type USD Million (2021-2026)
  • Table 151. Japan E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 152. Japan E Coli Testing, by End User USD Million (2021-2026)
  • Table 153. India E Coli Testing, by Type USD Million (2021-2026)
  • Table 154. India E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 155. India E Coli Testing, by End User USD Million (2021-2026)
  • Table 156. South Korea E Coli Testing, by Type USD Million (2021-2026)
  • Table 157. South Korea E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 158. South Korea E Coli Testing, by End User USD Million (2021-2026)
  • Table 159. Taiwan E Coli Testing, by Type USD Million (2021-2026)
  • Table 160. Taiwan E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 161. Taiwan E Coli Testing, by End User USD Million (2021-2026)
  • Table 162. Australia E Coli Testing, by Type USD Million (2021-2026)
  • Table 163. Australia E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 164. Australia E Coli Testing, by End User USD Million (2021-2026)
  • Table 165. Rest of Asia-Pacific E Coli Testing, by Type USD Million (2021-2026)
  • Table 166. Rest of Asia-Pacific E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 167. Rest of Asia-Pacific E Coli Testing, by End User USD Million (2021-2026)
  • Table 168. Europe E Coli Testing, by Country USD Million (2021-2026)
  • Table 169. Europe E Coli Testing, by Type USD Million (2021-2026)
  • Table 170. Europe E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 171. Europe E Coli Testing, by End User USD Million (2021-2026)
  • Table 172. Germany E Coli Testing, by Type USD Million (2021-2026)
  • Table 173. Germany E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 174. Germany E Coli Testing, by End User USD Million (2021-2026)
  • Table 175. France E Coli Testing, by Type USD Million (2021-2026)
  • Table 176. France E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 177. France E Coli Testing, by End User USD Million (2021-2026)
  • Table 178. Italy E Coli Testing, by Type USD Million (2021-2026)
  • Table 179. Italy E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 180. Italy E Coli Testing, by End User USD Million (2021-2026)
  • Table 181. United Kingdom E Coli Testing, by Type USD Million (2021-2026)
  • Table 182. United Kingdom E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 183. United Kingdom E Coli Testing, by End User USD Million (2021-2026)
  • Table 184. Netherlands E Coli Testing, by Type USD Million (2021-2026)
  • Table 185. Netherlands E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 186. Netherlands E Coli Testing, by End User USD Million (2021-2026)
  • Table 187. Rest of Europe E Coli Testing, by Type USD Million (2021-2026)
  • Table 188. Rest of Europe E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 189. Rest of Europe E Coli Testing, by End User USD Million (2021-2026)
  • Table 190. MEA E Coli Testing, by Country USD Million (2021-2026)
  • Table 191. MEA E Coli Testing, by Type USD Million (2021-2026)
  • Table 192. MEA E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 193. MEA E Coli Testing, by End User USD Million (2021-2026)
  • Table 194. Middle East E Coli Testing, by Type USD Million (2021-2026)
  • Table 195. Middle East E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 196. Middle East E Coli Testing, by End User USD Million (2021-2026)
  • Table 197. Africa E Coli Testing, by Type USD Million (2021-2026)
  • Table 198. Africa E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 199. Africa E Coli Testing, by End User USD Million (2021-2026)
  • Table 200. North America E Coli Testing, by Country USD Million (2021-2026)
  • Table 201. North America E Coli Testing, by Type USD Million (2021-2026)
  • Table 202. North America E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 203. North America E Coli Testing, by End User USD Million (2021-2026)
  • Table 204. United States E Coli Testing, by Type USD Million (2021-2026)
  • Table 205. United States E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 206. United States E Coli Testing, by End User USD Million (2021-2026)
  • Table 207. Canada E Coli Testing, by Type USD Million (2021-2026)
  • Table 208. Canada E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 209. Canada E Coli Testing, by End User USD Million (2021-2026)
  • Table 210. Mexico E Coli Testing, by Type USD Million (2021-2026)
  • Table 211. Mexico E Coli Testing, by Environmental Testing USD Million (2021-2026)
  • Table 212. Mexico E Coli Testing, by End User USD Million (2021-2026)
  • Table 213. Research Programs/Design for This Report
  • Table 214. Key Data Information from Secondary Sources
  • Table 215. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global E Coli Testing: by Type USD Million (2015-2020)
  • Figure 5. Global E Coli Testing: by Environmental Testing USD Million (2015-2020)
  • Figure 6. Global E Coli Testing: by End User USD Million (2015-2020)
  • Figure 7. South America E Coli Testing Share (%), by Country
  • Figure 8. Asia Pacific E Coli Testing Share (%), by Country
  • Figure 9. Europe E Coli Testing Share (%), by Country
  • Figure 10. MEA E Coli Testing Share (%), by Country
  • Figure 11. North America E Coli Testing Share (%), by Country
  • Figure 12. Global E Coli Testing share by Players 2020 (%)
  • Figure 13. Global E Coli Testing share by Players (Top 3) 2020(%)
  • Figure 14. Global E Coli Testing share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Alere (United States) Revenue, Net Income and Gross profit
  • Figure 17. Alere (United States) Revenue: by Geography 2020
  • Figure 18. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 19. Becton, Dickinson and Company (United States) Revenue: by Geography 2020
  • Figure 20. BioMerieux (France) Revenue, Net Income and Gross profit
  • Figure 21. BioMerieux (France) Revenue: by Geography 2020
  • Figure 22. Meridian Bioscience (United States) Revenue, Net Income and Gross profit
  • Figure 23. Meridian Bioscience (United States) Revenue: by Geography 2020
  • Figure 24. Accugen Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 25. Accugen Laboratories (United States) Revenue: by Geography 2020
  • Figure 26. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 27. Bio-Rad Laboratories (United States) Revenue: by Geography 2020
  • Figure 28. Diasorin (Italy) Revenue, Net Income and Gross profit
  • Figure 29. Diasorin (Italy) Revenue: by Geography 2020
  • Figure 30. EIKEN CHEMICAL (Japan) Revenue, Net Income and Gross profit
  • Figure 31. EIKEN CHEMICAL (Japan) Revenue: by Geography 2020
  • Figure 32. Enzo Life Sciences (United States) Revenue, Net Income and Gross profit
  • Figure 33. Enzo Life Sciences (United States) Revenue: by Geography 2020
  • Figure 34. InstantLabs (United States) Revenue, Net Income and Gross profit
  • Figure 35. InstantLabs (United States) Revenue: by Geography 2020
  • Figure 36. Global E Coli Testing: by Type USD Million (2021-2026)
  • Figure 37. Global E Coli Testing: by Environmental Testing USD Million (2021-2026)
  • Figure 38. Global E Coli Testing: by End User USD Million (2021-2026)
  • Figure 39. South America E Coli Testing Share (%), by Country
  • Figure 40. Asia Pacific E Coli Testing Share (%), by Country
  • Figure 41. Europe E Coli Testing Share (%), by Country
  • Figure 42. MEA E Coli Testing Share (%), by Country
  • Figure 43. North America E Coli Testing Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Alere (United States)
  • Becton, Dickinson and Company (United States)
  • BioMerieux (France)
  • Meridian Bioscience (United States)
  • Accugen Laboratories (United States)
  • Bio-Rad Laboratories (United States)
  • Diasorin (Italy)
  • EIKEN CHEMICAL (Japan)
  • Enzo Life Sciences (United States)
  • InstantLabs (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation